雷蛇(01337.HK)续挫11%失配股价创逾两个月低 遭大股东及主要股东配股「抽水」6.61亿元
雷蛇(01337.HK)遭大股东及主要股东折让7.5%配股「抽水」6.61亿元,该股承昨天失守百天线势,今早进一步跌破10天及20天线,最低见2.28元,创逾两个月低,半日收2.31元,急挫11%,半日成交受配股上板带动急增至3.727亿股,涉资8.9亿元。
雷蛇公布,公司主席兼首席执行官陈民亮及非执董LIM Kaling拟以每股2.405元(较昨天收市价折让7.5%),合共配售2.75亿股份或占公司已发行股本3.09%,套现6.61亿元。於配售完成後,陈民亮及LIM Kaling之持股比例分别降至33.76%及23.06%,仍为公司控股股东及主要股东。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.